Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Regulatorischer Schlag aus China: Aktie von Up Fintech bricht ein (Investing.com DE) +++ UP FINTECH Aktie +9,80%

VITROLIFE Aktie

 >VITROLIFE Aktienkurs 
9.73 EUR    (TradegateBSX)
Ask: 9.75 EUR / 1025 Stück
Bid: 9.71 EUR / 1030 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
VITROLIFE Aktie über LYNX handeln
>VITROLIFE Performance
1 Woche: +2,4%
1 Monat: -1,7%
3 Monate: +18,1%
6 Monate: -22,4%
1 Jahr: -31,1%
laufendes Jahr: -20,6%
>VITROLIFE Aktie
Name:  VITROLIFE AB SK 0,2
Land:  Schweden
Sektor:  Gesundheit
ISIN/ Wkn:  SE0011205202 / A2JLT3
Symbol/ Ticker:  VTFN (Frankfurt)
Kürzel:  FRA:VTFN, ETR:VTFN, VTFN:GR
Index:  -
Webseite:  https://www.vitrolife.com..
Profil:  Vitrolife AB is a leading global provider of medical devices and genetic testing services dedicated to the reproductive-health market, specializing in assisted reproduction technologies. The company develops, manufactures, and distributes specialized..
>Volltext..
Marktkapitalisierung:  1343.47 Mio. EUR
Unternehmenswert:  1407.06 Mio. EUR
Umsatz:  308.23 Mio. EUR
EBITDA:  92.45 Mio. EUR
Nettogewinn:  -453.74 Mio. EUR
Gewinn je Aktie:  -3.35 EUR
Schulden:  143.25 Mio. EUR
Liquide Mittel:  80.23 Mio. EUR
Operativer Cashflow:  -
Bargeldquote:  1.5
Umsatzwachstum:  -6.34%
Gewinnwachstum:  -1097.18%
Dividende je Aktie:  0.1 EUR
Dividendenrendite:  1.02%
Dividendenschätzung:  1.04%
Div. Historie:  06.05.26 - 0.100815006€
30.04.25 - 0.099451005€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  VITROLIFE
Letzte Datenerhebung:  22.05.26
>VITROLIFE Kennzahlen
Aktien/ Unternehmen:
Aktien: 135.42 Mio. St.
Frei handelbar: 51.98%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 1151
Umsatz/Mitarb.: 0.28 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 39.22%
Bewertung:
KGV: -
KGV lG: 26.15
KUV: 4.27
KBV: 1.78
PEG-Ratio: -
EV/EBITDA: 15.22
Rentabilität:
Bruttomarge: 51.41%
Gewinnmarge: -147.21%
Operative Marge: 17.54%
Managementeffizenz:
Gesamtkaprendite: -35.95%
Eigenkaprendite: -47.29%
>VITROLIFE Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
22.05.26 - 12:54
CEO Bronwyn Brophy O′Connor has decided to leave Vitrolife Group (PR Newswire)
 
GOTHENBURG, Sweden, May 22, 2026 /PRNewswire/ -- Vitrolife AB (publ) today announces that CEO Bronwyn Brophy O'Connor has decided to leave the company to assume a CEO role in a different area of the medtech industry. Vitrolife Group's Board has received Bronwyn's resignation and will......
05.05.26 - 18:54
Report from the Annual General Meeting of Vitrolife AB (publ) (PR Newswire)
 
The Annual General Meeting of Vitrolife AB (publ) was held today on Tuesday 5 May 2026. The Annual General Meeting resolved in accordance with all proposals presented by the Board and the Nomination Committee. GOTHENBURG, Sweden, May 5, 2026 /PRNewswire/ -- The Annual General Meeting......
05.05.26 - 18:36
Report from the Annual General Meeting of Vitrolife AB (publ) (Cision)
 
The Annual General Meeting of Vitrolife AB (publ) was held today on Tuesday 5 May 2026. The Annual General Meeting resolved in accordance with all proposals presented by the Board and the Nomination Committee. The Annual General Meeting resolved to re-elect the Board members Henrik Blomquist, Karen Lykke Sørensen, Pia Marions and Jón Sigurdsson, and to elect Nicklas Hansen and David T. Hansen as new Board members. Jón Sigurdsson was re-elected as Chairman of the Board. The Annual General Meeting adopted the Income Statements and Balance Sheets for the parent company and the group and...
28.04.26 - 20:36
Vitrolife: Aktie steigt trotz verfehlter Q1-Erwartungen (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
23.04.26 - 18:39
Vitrolife AB (publ) GAAP EPS of SEK0.74, revenue of SEK842M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
23.04.26 - 11:24
Vitrolife Q1 2026: Gewinnziel verfehlt, Aktie dennoch im Aufwind (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
23.04.26 - 08:24
Vitrolife AB (publ) - Interim report Q1, 2026: Strong growth in Consumables and Technologies (PR Newswire)
 
GOTHENBURG, Sweden, April 23, 2026 /PRNewswire/ -- First quarter Sales of SEK 807 (842) million, an increase of 5% in local currencies and 4% decrease in SEK. Sales per region, in local currencies, were -1% in EMEA, +11% in Americas and +7% in APAC. Sales per product group, in local......
09.04.26 - 09:31
Invitation to Vitrolife Group′s presentation of the Q1 2026 interim report (PR Newswire)
 
GOTHENBURG, Sweden, April 9, 2026 /PRNewswire/ -- Vitrolife AB (publ) will publish its Q1 2026 interim report on Thursday, 23 April 2026 at 08:00 am CET. A conference call for investors, analysts and financial media will be held at 10:00 am CET the same day. The presentation will be held......
01.04.26 - 18:48
Notice of the Annual General Meeting of Vitrolife AB (publ) (PR Newswire)
 
GOTHENBURG, Sweden, April 1, 2026 /PRNewswire/ -- The Annual General Meeting of Vitrolife AB (publ), 556354-3452, will be held on Tuesday 5 May 2026 at 17:00 CEST at Elite Park Avenue Hotel, Kungsportsavenyn 36-38 in Gothenburg, Sweden. Registration for the Annual General Meeting will......
01.04.26 - 17:54
The Nomination Committee proposes two new Board members (Cision)
 
Vitrolife AB (publ) ("Vitrolife") today announced that its Nomination Committee proposes the election of Nicklas Hansen and David T. Hansen as new Board members. The Committee further proposes the re-election of Jón Sigurdsson as Chairman of the Board, as well as all current Board members except Lars Holmqvist, who has decided not to stand for re-election at the 2026 Annual General Meeting. Nicklas Hansen is Chief Investment Officer at Vitrolife's largest shareholder, William Demant Invest A/S, where he is responsible for its investment portfolio. He has held several positions at William...
26.03.26 - 16:19
Vitrolife AB (publ) Non-GAAP EPS of $0.66, revenue of $891M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.03.26 - 09:21
Vitrolife Group has today published its Annual and Sustainability Report for 2025 (PR Newswire)
 
GOTHENBURG, Sweden, March 26, 2026 /PRNewswire/ -- The Annual and Sustainability Report is now available digitally in English and Swedish at www.vitrolifegroup.com. The Annual Report in accordance with European Single Electronic Format (ESEF) is available in Swedish. Vitrolife Group has......
26.03.26 - 09:01
Vitrolife Group has today published its Annual and Sustainability Report for 2025 (Cision)
 
The Annual and Sustainability Report is now available digitally in English and Swedish at www.vitrolifegroup.com. The Annual Report in accordance with European Single Electronic Format (ESEF) is available in Swedish. Vitrolife Group has chosen not to print or distribute a hard copy of the Annual Report. Those who are unable to access the Annual Report digitally can request a print-out of the Annual Report by contacting Vitrolife Group at investors@vitrolife.com or call +46 (0) 31 721 80 00. Gothenburg, Sweden March 26, 2026 VITROLIFE AB (publ)...
03.02.26 - 08:27
Vitrolife AB (publ) - Fourth quarter and full year report 2025 (PR Newswire)
 
GOTHENBURG, Sweden, Feb. 3, 2026 /PRNewswire/ -- Fourth quarter Sales of SEK 891 (959) million, organic growth in local currencies excluding discontinued business* were 6%, 3% growth in local currencies and 7% decrease in SEK, due to a significant currency impact of -10%. Sales per......
20.01.26 - 18:12
Invitation to Vitrolife Group′s presentation of the fourth quarter and full year report 2025 (PR Newswire)
 
GOTHENBURG, Sweden, Jan. 20, 2026 /PRNewswire/ -- Vitrolife AB (publ) will publish its fourth quarter and full year report 2025 on Tuesday, 3 February 2026 at 08:00 am CET. A conference call for investors, analysts and financial media will be held at 10:00 am CET the same day. The......
16.12.25 - 19:57
Vitrolife announces genetic services restructuring program targeting annualised savings of 65 MSEK and recognises a 5.4 BSEK goodwill impairment (PR Newswire)
 
GOTHENBURG, Sweden, Dec. 16, 2025 /PRNewswire/ -- Vitrolife AB (publ) ("Vitrolife") today announced that following a strategic review it will execute a restructuring program of its genetic services business. The program is targeting annualised savings of SEK 65 million, expected to have a......
29.10.25 - 09:30
Nomination committee of Vitrolife AB (publ) for the Annual General Meeting 2026 (PR Newswire)
 
GOTHENBURG, Sweden, Oct. 29, 2025 /PRNewswire/ -- In accordance with the Nomination Committee Charter adopted at the Annual General Meeting 2025, the members who, together with the Chair of the Board, constitute the Nomination Committee in preparation of the Annual General Meeting 2026......
23.10.25 - 11:42
Vitrolife meldet Umsatzwachstum für Q3 2025 – Aktie legt zu (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
23.10.25 - 08:42
Vitrolife AB (publ) - Interim report Q3, 2025: Strong growth in Americas (PR Newswire)
 
GOTHENBURG, Sweden, Oct. 23, 2025 /PRNewswire/ -- Third quarter Sales of SEK 835 (867) million, 3% growth in local currencies and a 4% decrease in SEK, due to a significant currency impact of -7%. Organic growth in local currencies excluding discontinued business* was 5%. Sales per......
17.10.25 - 14:18
AKTIONÄR-Altempfehlung Vitrolife springt hoch – Trump macht ernst (Der Aktionaer)
 
Spannende Entwicklungen in den USA: Präsident Donald Trump hat am Donnerstag Maßnahmen zur Kostensenkung und zur Verbesserung des Zugangs zu In-vitro-Fertilisation (IVF) und hochwertiger Fertilitätsbehandlung angekündigt. Die Aktie der AKTIONÄR-Altempfehlung Vitrolife verzeichnet daraufhin einen Kurssprung von rund sechs Prozent an der Börse in Stockholm....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Keine Blume blüht hundert Tage lang, und niemand ist tausend Tage lang gut. - Sprichwort China
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!